Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001447028-25-000059
Filing Date
2025-03-06
Accepted
2025-03-06 16:07:01
Documents
3
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1741295212.html 3  
1 FORM 3 wk-form3_1741295212.xml 3 2995
2 EX-24 abus-secfilingspowerofat.htm EX-24 4038
3 abus-secfilingspowerofat001.jpg GRAPHIC 277141
  Complete submission text file 0001447028-25-000059.txt   390515
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROIVANT SCIENCES, INC. 151 W. 42ND ST., 15TH FLOOR NEW YORK NY 10036
Business Address
Gline Matthew (Reporting) CIK: 0001750094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 25715237